🔴 BioLineRx is trading 20.14% down in pre-market after no company-specific announcement was identified

BioLineRx is trading at $2.22, down -20.14%, after no company-specific announcement was identified for August 28, 2026.

• The latest company release announced second-quarter 2026 results for August 31, 2026, before markets open.
• BioLineRx’s investor-relations page shows no newer release dated August 27 or August 28.
• Broader pre-market conditions were mixed and do not clearly explain the decline.